top of page

Meet the Team

Our mission-driven team is united by a shared sense of purpose and urgency: to bring a life-changing treatment to CMT1A patients as quickly as possible.

Ari on my shoulders
David Apple | Founder & CEO

Dedication. 

- My 5 yr old son Ari has CMT1A.

- Ari had an earlier onset and has a severe presentation.

- CMT1A is progressive, and is reported to get worse during puberty.

- I have a sense of urgency and will not stop until a treatment is available for Ari.

 

Track-record.  

- I'm a Mech Eng (Johns Hopkins) and an MBA (Imperial College London).

- I was the first go-to-market leader at Notion ($10B) and Typeform ($1B). 

- I advise Sequoia Capital, First Round Capital, and Headline Ventures.

- 3x Founder. Teleconnect (acquired), Apple Sustainability (ran profitably 5 yrs).

 

Perspective.

- I'm energized by solving hard problems. 

- I'm working backwards from the unmet need.

- I'm a Board Member of the CMT Association.

Leadership Team

Our Scientific Advisors.

Symbol + Wordmark - Dark - Square.png

Developing treatments for CMT1A, and unlocking solutions for other neuropathies.​

Follow Us:

  • LinkedIn
  • Twitter

© 2024 by Shark Tooth Biotech. All rights reserved.

bottom of page